Regeneron Pharmaceuticals had previously agreed to acquire the company for $256 million. TTAM’s higher bid and added consumer protections ultimately led the board’s special committee to select it as ...

US stocks fell, with investors on edge as Israel and Iran continued to trade strikes against a backdrop of shifting US trade ...